Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,856Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12BRISTOL MYERS SQUIBB

02 84HANDA THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

02

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

03

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

04

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

05

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

06

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

07

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

blank

08

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

blank

09

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

blank

10

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DASATINIB

US Patent Number : 7491725*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-28

blank